TF and neoplasm: Tumor-specific ligand-like peptides [12, 13], galactose-conjugated chitosan [14], transferrin [15], folic acid [16–19], and monoclonal antibodies [20–22] have been employed to target microbubbles to tumor cells for the treatment of many cancers.